These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24358221)

  • 1. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
    Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
    PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
    Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
    Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.
    Tang Z; Yu W; Zhang C; Zhao S; Yu Z; Xiao X; Tang R; Xuan Y; Yang W; Hao J; Xu T; Zhang Q; Huang W; Deng W; Guo W
    Mol Oncol; 2016 Feb; 10(2):317-29. PubMed ID: 26628108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.
    Yang Q; Fan W; Zheng Z; Lin S; Liu C; Wang R; Li W; Zuo Y; Sun Y; Hu S; Chen M; Guo P; Pan J; Tian C; Zhu T; Diao C; Hao J; Yu W; Li L; Li Y; Guo W; Deng W; Wu X
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1533-1543. PubMed ID: 31301362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Zhang M; Lin H; Ge X; Xu Y
    J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4.
    Wu J; Miao J; Ding Y; Zhang Y; Huang X; Zhou X; Tang R
    Biochem Cell Biol; 2019 Dec; 97(6):722-730. PubMed ID: 30970220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
    Song Y; Sun K; Gong L; Shi L; Qin T; Wang S; Deng W; Chen W; Zheng F; Li G
    Med Oncol; 2022 Dec; 40(1):62. PubMed ID: 36567417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.
    Fu L; Shi K; Wang J; Chen W; Shi D; Tian Y; Guo W; Yu W; Xiao X; Kang T; Wang S; Huang W; Deng W
    Mol Cancer; 2014 Apr; 13():89. PubMed ID: 24766673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma.
    Zu Y; Wang D; Ping W; Sun W
    Aging (Albany NY); 2022 Nov; 14(22):9300-9316. PubMed ID: 36446361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.
    Choudhry M; Gamallat Y; Ghosh S; Bismar TA
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
    Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
    BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4.
    Lee K; Zheng Q; Lu Q; Xu F; Qin G; Zhai Q; Hong R; Chen M; Deng W; Wang S
    Signal Transduct Target Ther; 2021 May; 6(1):184. PubMed ID: 34006850
    [No Abstract]   [Full Text] [Related]  

  • 17. Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
    Zhang N; Xie Y; Tai Y; Gao Y; Guo W; Yu W; Li J; Feng X; Hao J; Gao Y; Zhao X; Liao Y; Jiang W; Liu G; Deng W; Cui X
    Cell Physiol Biochem; 2016; 40(6):1559-1569. PubMed ID: 27997899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
    Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
    Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
    Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
    Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
    Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
    J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.